AKERBLOM, J.S, CANNON, C, EMANUELSSON, G, ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndrome: Rationale, design and baseline characteristics of the PLATelet inhibition and patient Outcome trial.: PLATO American Heart Journal. 157, 599-605
CARVER, A, RAFELT, S, GERSHLICK, A.H, FAIRBROTHER, K.L, HUGHES, S and WILCOX, R.G. FOR THE REACT INVESTIGATORS., 2009. Longer-Term Follow-Up of Patients Recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial Journal of the American College of Cardiology. 54(2),
MEGA, J.L, BRAUNWALD, E, MOHANAVELU, S and ET AL (WILCOX, R.G. STEERING COMMITTEE AND UK LEAD INVESTIGATOR), 2009. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. The Lancet. 374, 29-38
WALLENTIN, L., BECKER, R.C., BUDAJ, A., CANNON, C.P., ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome: PLATO The New England Journal of Medicine. 361(11), 1045-1057
TANGELDER, M, FRISON, L, WEAVER, D, WILCOX, R, BYLOCK, A, EMANUELSSON, H, HELD, P and AND OLDGREN, J., 2008. American Heart Journal. 155(2), 382-387
WILCOX, R.G, KUPFER, S, AND ERDMANN, E and ON BEHALF OF THE PROACTIVE STUDY INVESTIGATORS., 2008. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial in macro Vascular Events (PROactive 10) American Heart Journal. 155(1), (In Press.)
ALP, N.J, GERSHLICK, A.H, CARVER, A, STEVENS, S.E and WILCOX, R.G., 2008. Rescue angioplasty for failed thrombolysis in older patients: Insights from the REACT trial. International Journal of Cardiology. 125(2), 254-257
ERDMANN, E and AND WILCOX, R.G., 2008. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure European Heart Journal. 29(1), 12-20
WILCOX, R., BOUSSER, M-G., PIRAG, V., BETTERIDGE, J., SCHERNTHANER, G., KUPFER, S. and DORMANDY, J., 2007. Stroke. 38(3), 865-873
XAVIER, R, WHITE, A, FOX, S, WILCOX, R and AND HEPTINSTALL, S., 2007. Enhanced platelet aggregation and activation under conditions of hypothermia Thrombosis and Haemostasis. 98(6), 1266-1275
STOREY, R., HARRINGTON, R, A., HUSTED, S., HEPTINSTALL, S., WILCOX, R., GURBEL, A., GRANDE, P., WICKENS, M., PETERS, G., EMANUELSSON, H. and CANNON, C., 2007. AZD6140 Suppresses Platelet Aggregation in Clopidogrel-Treated Patients Even in Those With High Aggregation Levels JACC. 49(9 (Supplement A)),
STOREY, R.F, HUSTED, S, HARRINGTON, R.A, HEPTINSTALL, S, WILCOX, R.G, PETERS, G, WICKENS, M, EMANUELSSON, H, GURBEL, P, GRANDE, P and AND CANNON, C.P., 2007. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. 50(19), 1852-1856 (In Press.)
ERDMANN, E., WILCOX, R., PEREZ, A., YATES, J., SPANHEIMER, R. and DORMANDY, J., 2007. Mortality after Serious Heart Failure: Results from PROactive JACC. 49(9), 66A
ERDMANN, E, DORMANDY, J, WILCOX, R, MASSI-BENEDETTI, M and AND CHARBONNEL, B., 2007. PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactuve study Vascular Health and Risk Management. 3(4), 355-370
WIVIOTT, S.D, BRAUNWALD, E, MCCABE, C.H and ET AL. (WILCOX, R.G. UK PRINCIPAL INVESTIGATOR AND STEERING COMMITTEE MEMBER)., 2007. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. 357(20), 2001-15 (In Press.)
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 RAO, ARCHANA, ASADI-LARI, MOHSEN, WALSH, JOHN, WILCOX, ROBERT and GRAY, DAVID, 2006. Journal of cardiac failure. 12(9), 677-83
HOUGHTON A. and GRAY D., 2006. In: HODDER, ed., Making Sense of the ECG. A hands-on guide.: International Student's Edition 2nd ed. Edward Arnold. 278
STOREY R.F., HUSTED S, HARRINGTON R.A., HEPTINSTALL S., WILCOX R.G. and ET AL., 2006. AZD6140 Yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. In: 204 (A821)
WILCOX, R.G., BOUSSER, M-G. and DORMANDY, J. ON BEHALF OF THE PROACTIVE INVESTIGATORS., 2006. The effects of pioglitazone in patients with or without a history of stroke (> 6 months prior to randomisation) - a pre-specified subgroup analysis of PROactive. In: World Congress of Cardiology. A204 (no 821-4).
STOREY R.F., HARRINGTON R.A., HUSTED S., HEPTINSTALLS., WILCOX R.G. and ET AL, 2006. AZD6140 Yields additional suppression of platelet aggregation in patients with acute coronary syndrome previously treated with clopidogrel. In: 204 (A821-4)
WILCOX, R., 2006. An Analysis from PROactive on the effects of pioglitazone on major adverse cardiovascular events (MACE) and myocardial infarction. Diabetologia. 49 (Supplement 1)(72),
WILCOX, R., 2006. An analysis from PROactive on the Effects of Pioglitazone on Myocardial Infarction and Major Adverse Cardiovascular Events (MACE) in Patients with Type 2 Diabetes (Abstract). European Heart Journal. 27(supplement)(535),
BODY, S., ASGARI, K., RICKARD, J. F., ZHANG, Z., FONE, K. C., BRADSHAW, C. M. and SZABADI, E., 2005. Psychopharmacology. VOL 181(NUMBER 2), 289-298
GERSHLICK, A.H., STEPHENS-LLOYD, A., HUGHES, S., ABRAMS, K.R., STEVENS, S.E., UREN, N.G., DE BELDER, A., DAVIS, J., PITT, M., BANNING, A., BAUMBACH, A., SHIU, M.F., SCHOFIELD, P., DAWKINS, K.D., HENDERSON, R.A., OLDROYD, K. and WILCOX, R.G., 2005. New England Journal of Medicine. 353(26), 2758-2768
DORMANDY, J.A., CHARBONNEL, B., ECKLAND, D.J.A., ERDMANN, E., MASSI-BENEDETTI, M., MOULES, I.K., SKENE, A.M., TAN, M.H., LEF脠BVRE, P.J., MURRAY, G.D., STANDL, E., WILCOX, R.G., WILHELMSEN, L., BETTERIDGE, J., BIRKELAND, K., GOLAY, A., HEINE, R.J., KOR脕NYI, L., LAAKSO, M., MOK脕艊, M., NORKUS, A., PIRAGS, V., PODAR, T., SCHEEN, A., SCHERBAUM, W., SCHERNTHANER, G., SCHMITZ, O., 艩KRHA, J., SMITH, U., TATO艊, J. and ON BEHALF OF THE PROACTIVE INVESTIGATORS, 2005. Lancet. 366(9493), 1279-1289
SABATINE, M.S., CANNON C.P., GIBSON, C.M., L脫PEZ-SEND脫N, J.L., MONTALESCOT, G., THEROUX, P., CLAEYS, M.J., COOLS, F., HILL, K.A., SKENE, A.M., MCCABE, C.H. and BRAUNWALD, E., 2005. New England Journal of Medicine. 352(12), 1179-1189
WILCOX,R.G., 2005. General principles of fibrinolytic therapy in acute myocardial infarction.. In: Coronary Reperfusion Therapy in Clinical Practice. Taylor & Francis Ltd, London. 43-64
GERSHLICK, A.H., HUGHES, S.L., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed lysis: 6 months outcome according to treatment actually received In: European Society of Cardiology, Stockholm September 2005. P3426, p562
BRENER, S. J., LINCOFF, A. M., BATES, E. R., JIA, G., ARMSTRONG, P. W., GUETTA, V., HOCHMAN, J. S., SAVONITTO, S., WILCOX, R. G. and WHITE, H. D., 2005. American Heart Journal. VOL 150(NUMBER 1), 89-93
GERSHLICK, A.H., HUGHES, S. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Impact of age upon efficacy of treatment. In: British Cardiac Society proceedings. A24
TOFF, W.D., CAMM, A.J., SKEHAN, D. and (WILCOX, R.G. INVESTIGATOR), 2005. New England Journal of Medicine. 353(2), 145-155
GERSHLICK, A.H., UREN, N., DE BELDER, A. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Results according to actual treatment received. In: British Cardiac Society, Annual Scientific Conference, 23-26 May 2005. A22, No A063
GURM, H. S., SAREMBOCK, I. J., KEREIAKES, J., YOUNG, J. J., HARRINGTON, R. A., KLEIMAN, N., FEIT, F., WOLSKI, K., BITTL, J. A. and WILCOX, R., 2005. American College of Cardiology. Journal. VOL 45(NUMB 12), 1932-1938
NALLAMOTHU, BRAHMAJEE K, BATES, ERIC R, HOCHMAN, JUDITH S, GRANGER, CHRISTOPHER B, GUETTA, VICTOR, WILCOX, ROBERT G, WHITE, HARVEY D, ARMSTRONG, PAUL W, SAVONITTO, STEFANO, JIA, GANG and LINCOFF, A MICHA, 2005. European Heart Journal. 26(15), 1506-12
PITT B, WHITE H, NICOLAU J, ET AL (WILCOX, R.G. STEERING COMMITTEE MEMBER AND UK LEAD INVESTIGATOR)., 2005. American College of Cardiology. Journal. 46, 425
WILCOX, R.G., AMBROSIONI R., PATNI R., MUKERHERJEE R. and PITT B., 2005. Effect of eplerenone in patients with normal renal function and mild renal insufficiency: results from the EPHESUS trial. In: European Society of Cardiology.. PO P1772
GERSHLICK, A.H., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed thrombolysis in acute MI: the REACT trial one year clinical outcome. In: European Society of Cardiology, Stockholm, Sept 2005. 562
FOX, K. A. A., BIRKHEAD, J., WILCOX, R., KNIGHT, C. and BARTH, J., 2004. Heart. VOL 90(PART 6), 603-609
SAW, J., LINCOFF, A. M., DESMET, W., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., WOLSKI, K., TOPOL, E. J. and REPLACE-2 INVESTIGATORS, 2004. American College of Cardiology. Journal. VOL 44(NUMB 6), 1194-1199
CHARBONNEL, B., DORMANDY, J., ERDMANN, E., MASSI-BENEDETTI, M., SKENE, A.M. and WILCOX, R.G., 2004. Diabetes Care. 27(7), 1647-1653
LINCOFF, A MICHAEL, KLEIMAN, NEAL S, KEREIAKES, DEAN J, FEIT, FREDERICK, BITTL, JOHN A, JACKMAN, J DANIEL, SAREMBOCK, IAN J, COHEN, DAVID J, SPRIGGS, DOUGLAS, EBRAHIMI, RAMIN, KEREN, GADI, CARR, JEFFREY, COHEN, ERIC A, BETRIU, AMADEO, DESMET, WALTER, RUTSCH, WOLFGANG, WILCOX, ROBERT G, DE FEYTER, PIM J, VAHANIAN, ALEC, TOPOL, ERIC J and ,, 2004. Journal of the American Medical Association. 292(6), 696-703
GURM, HITINDER S, LINCOFF, A MICHAEL, LEE, DAVID, TANG, W H WILSON, JIA, GANG, BOOTH, JOAN E, CALIFF, ROBERT M, OHMAN, E M, VAN DE WERF, FRANS, ARMSTRONG, PAUL W, GUETTA, VICTOR, WILCOX, ROBERT, TOPOL, ERIC J and ,, 2004. American College of Cardiology. Journal. 43(4), 542-8
WILCOX, R.G., 2004. Combination of the oral direct thrombin inhibitor Ximelagatran with acetyl salicylic acid (ASA) after acute myocardial infarction (MI): 1 year outcome following the start of 6 months treatment. Heart. 90(Suppl 2), 153
MENON, V., HARRINGTON, R. A., HOCHMAN, J. S., CANNON, C. P., GOODMAN, S. D., WILCOX, R. G., SCHUNEMANN, H. J. and OHMAN, E. M., 2004. Chest. VOL 126(NUMB 3), 549S-575S
PATRONO, C. and WILCOX, R.G., 2004. European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. European Heart Journal. 25(2), 166-181
WALLENTIN, L., WILCOX, R.G., WEAVER, W.D., EMANUELSSON, H., GOODVIN, A., NYSTR脰M, P. and BYLOCK, A., 2003. Lancet. 362(9386), 789-797
PITT B., REMME W., ZANNAD F., ET AL and (WILCOX, R.G. STEERING COMMITTEE MEMBER AND UK PRINCIPAL INVESTIGATOR)., 2003. New England Journal of Medicine. 348(14), 1309-1321
HO, M.-Y., BODY, S., KHERAMIN, S., BRADSHAW, C. M. and SZABADI, E., 2003. Psychopharmacology. VOL 167(PART 2), 137-144
MCKENZIE, D.B. and WILCOX, R.G., 2003. Metformin and Chronic Heart Failure. Lancet. 362, 919.
MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Expert Opinion on Pharmacotherapy. 4(1), 41-54
MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Heart failure: treatment and ethnic origin. Lancet. 362(9387), 919
WALLENTIN, L.C., WILCOX, R.G., WEAVER, D., EMANUELSSON, H., GOODVIN, A., NYSTROM, P. and BYLOCK, A., 2003. Combination of the Oral Direct Thrombin Inhibitor Ximelagatran with Acetyl Salicylic Acid (ASA) after Acute myocardial infarction: 1-year Outcome. Clinical Science. IV-501Abs2284
CHO, LESLIE, BHATT, DEEPAK L, BRENNAN, DANIELLE, WILCOX, ROBERT G and TOPOL, ERIC J, 2003. American Journal of Cardiology. 91(6), 721-3
LINCOFF, A.M., WILCOX, R.G., BITTL, J.A. and HARRINGTON, R.A., 2003. Journal of the American Medical Association. 289(7), 853-63
BRADSHAW,C.M., 2003. Neuropharmacology. In: HALLIGAN,P.W., KISCHKA, U. and MARSHALL, J.C, eds., Handbook of Clinical Neuropsychology Oxford University Press. 445-469
WONG, C. K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J. and OHMAN, E. M., 2003. Cardiac Electrophysiology Review. VOL 7(NUMBER 3), 201-207
SAW, J., DESMET, W., LINCOFF, A.M., BETRIU, A., RUTCH, W., WILCOX, R.G., KLEIMAN, N.S. and TOPOL, E.J., 2003. Clopidogrel Pretreatment Does not Influence the Relative Efficacy of Bivalirudin with Provisional GPIIb/IIIa Blockade vs Heparin with Routine GPIIb/IIIa Blockade. A REPLACE-2 Substudy. Circulation (Baltimore). 108(17), Abs: 2597
ANDERSON, I. M., RICHELL, R. A. and BRADSHAW, C. M., 2003. Journal of Psychopharmacology. VOL 17(PART 1), 3-8
DESMET, W., SAW, J., LINCOFF, A. M., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., TOPOL, E. J. and REPLACE-2, I., 2003. European Heart Journal. VOL 24(NUMBER 5), 548
WILCOX, R.G., 2003. General Principles of Fibrinolytic Therapy in Acute MI. In: Fibrinolytic Therapy in Clinical Practice
KHERAMIN, S., BODY, S., MOBINI, S., HO, M.Y., VELAZQUEZ-MARTINEZ, D.N., BRADSHAW, C.M., SZABADI, E., DEAKIN, J.F. and ANDERSON, I.M., 2002. Psychopharmacology. 165(1), 9-17
BOERSMA, ERIC, HARRINGTON, ROBERT A, MOLITERNO, DAVID J, WHITE, HARVEY, TH脡ROUX, PIERRE, VAN DE WERF, FRANS, DE TORBAL, ANNEKE, ARMSTRONG, PAUL W, WALLENTIN, LARS C, WILCOX, ROBERT G, SIMES, JOHN, CALIFF, ROBERT M, TOPOL, ERIC J and SIMOONS, MAARTEN L, 2002. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 359(9302), 189-98 BODY, S., CHIANG, T. J., MOBINI, S., HO, M. Y., BRADSHAW, C. M. and SZABADI, E., 2002. Pharmacology, Biochemistry and Behavior. VOL 71(NUMBER 4), 787-793
BODY, S., KHERAMIN, S., MOBINI, S., HO, M.-Y., VELAZQUEZ-MARTINEZ, D. N., BRADSHAW, C. M. and SZABADI, E., 2002. Behavioural Pharmacology. VOL 13(PART 8), 603-614
MOBINI, S, BODY, S, HO, M-Y, BRADSHAW, C M, SZABADI, E, DEAKIN, J F W and ANDERSON, I M, 2002. Psychopharmacology. 160(3), 290-8
GRAHAM, S J, LANGLEY, R W, BALBOA, VERDUZCO A M, BRADSHAW, C M and SZABADI, E, 2002. Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 16(1), 15-22
SZABADI, E., LANGLEY, R.W. and BRADSHAW, C.M., 2002. Comparison of single doses of noradrenergic drugs on pupillary fatigue waves in a patient with excessive daytime sleepiness Journal of Sleep Research. 11(JSR 11 (Suppl. 1)), 260
HO, M-Y, VEL脙隆ZQUEZ-MART脙颅NEZ, D N, BRADSHAW, C M and SZABADI, E, 2002. Pharmacology, Biochemistry and Behavior. 71(4), 773-85
LARGE, G.A., GRAY, D., WILCOX, R.G. and HAMPTON, J.R., 2002. Early revascularisation for non-ST-segment elevation acute coronary syndromes: an estimation of demand in the UK. European Heart Journal. 23((suppl S)), 585
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 2002. International Journal of Psychophysiology. VOL 43(NUMBER 2), 177-184
WONG, C.-K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J., OHMAN, E. M. and GUSTO-III INVESTIGATORS, 2002. Heart. VOL 88(PART 4), 357-362
O`SHEA, J. C., WILCOX, R. G., SKENE, A. M., STEBBINS, A. L., GRANGER, C. B., ARMSTRONG, P. W., BODE, C., ARDISSINO, D., EMANUELSSON, H. and AYLWARD, P. E., 2002. American Journal of Cardiology. VOL 90(NUMBER 12), 1374-1377
STOREY, R F, OLDROYD, K G and WILCOX, R G, 2001. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis and Haemostasis. 85(3), 401-7
BODY, S., CHIANG, T.-J., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2001. Psychopharmacology. VOL 158(PART 3), 305-313
GRAHAM, S. J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2001. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man Journal of Psychopharmacology. VOL 15(PART 4), 243-250
PRETORIUS, J L, PHILLIPS, M, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 2001. British Journal of Clinical Pharmacology. 52(3), 322-6
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2001. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. Journal of Psychopharmacology. 15(4), 237-42
ARONOW, H D, TOPOL, E J, ROE, M T, HOUGHTALING, P L, WOLSKI, K E, LINCOFF, A M, HARRINGTON, R A, CALIFF, R M, OHMAN, E M, KLEIMAN, N S, KELTAI, M, WILCOX, R G, VAHANIAN, A, ARMSTRONG, P W and LAUER, M S, 2001. Lancet. 357(9262), 1063-8
GIUGLIANO, R P, LLEVADOT, J, WILCOX, R G, GURFINKEL, E P, MCCABE, C H, CHARLESWORTH, A, THOMPSON, S L, ANTMAN, E M, BRAUNWALD, E and ,, 2001. European Heart Journal. 22(18), 1702-15
CANNON, C P, MCCABE, C H, WILCOX, R G, BENTLEY, J H and BRAUNWALD, E, 2001. American Journal of Cardiology. 87(5), 636-9, A10
WILCOX, R.G., 2001. Lancet. 357(June), 1915-1924
LLEVADOT, D., GIUGLIANO, R., ANTMAN, E., WILCOX, R.G., GURFINKEL, E., HENRY, T., MCCABE, C.H., CHARLESWORTH, A., THOMPSON, S., NICOLAU, J., SADOWSKI, Z. and BRAUNWALD, E., 2001. European Heart Journal. 22(22), 2104-2115
WILCOX, R.G., 2001. Lancet. 357(June), 1905-1914
WILCOX, R G, 2001. European Heart Journal. 22(9), 722-4
WILCOX, R.G., 2001. Lancet. 358, 1855-1863
BROOKS, J. and WILCOX, R.G., 2001. Guidelines for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation.
GIUGLIANO, R. P., MCCABE, C. H., ANTMAN, E. M., CANNON, C. P., VAN DE WERF, F., WILCOX, R. G., BRAUNWALD, E. and THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) INVESTIGATORS BOSTON, 2001. American Heart Journal. VOL 141(PART 5), 742-750
GREENBAUM, A B, HARRINGTON, R A, HUDSON, M P, MACAULAY, C M, WILCOX, R G, SIMOONS, M L, BERDAN, L G, GUERCI, A, COKKINOS, D V, KITT, M M, LINCOFF, A M, TOPOL, E J, CALIFF, R M and OHMAN, E M, 2001. American College of Cardiology. Journal. 37(2), 492-8
PHILLIPS, M A, OXTOBY, E K, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 14(3), 258-65
BANJAR, W. M. A., GAZZAZ, J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. British Journal of Clinical Pharmacology. VOL 50(PART 4), 360-365
DAVIS, C., LANGLEY, R.W., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Normative data on a computerized graded conditional discrimination (choice reaction time) task Clinical Neuropsychological Assessment. 3, 217-230
PHILLIPS, M. A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. The effects of some antidepressant durgs on prepulse inhibition of the acoustic startle (eyeblink) response and the NI/P2 auditory evoked response in man Journal of Psychopharmacology. VOL 14(PART 1), 40-45
TAVERNOR, S J, ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man. Journal of Psychopharmacology. 14(4), 387-94
PHILLIPS, M. A., SZABADI, E. and BRADSHAW, C. M., 2000. British Journal of Clinical Pharmacology. VOL 50(PART 1), 65-68
SZABADI, E. and BRADSHAW, C. M., 2000. Mechanisms of action of reboxetine Reviews in contemporary pharmacotherapy. VOL 11(PART 5), 267-282
CHIANG, T.-J., AL-RUWAITEA, A. S., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 150(PART 2), 170-184
PHILLIPS, M A, BITSIOS, P, SZABADI, E and BRADSHAW, C M, 2000. Psychopharmacology. 149(1), 72-6
DAVIS, C., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Estimation of premorbid performance on Raven's Standard Progressive Matrices using reading-test performance: New normative data Clinical Neuropsychological Assessment. 2, 113-123
MOBINI, S., CHIANG, T.-J., AL-RUWAITEA, A. S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 149(PART 3), 313-318
PHILLIPS, M. A., SZABADI, E. and BRADSHAW, C. M., 2000. Psychopharmacology. VOL 150(PART 1), 85-89
CHIANG, T.-J., AL-RUWAITEA, A. S. A., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 151(PART 4), 379-391
MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 152(PART 1), 47-54
MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Psychopharmacology. VOL 152(PART 4), 390-397
WONG, C K, WHITE, H D, WILCOX, R G, CRIGER, D A, CALIFF, R M, TOPOL, E J and OHMAN, E M, 2000. American Heart Journal. 140(6), 878-85
BOERSMA, E., PIEPER, K. S., STEYERBERG, E. W., WILCOX, R. G., CHANG, W.-C., LEE, K. L., AKKERHUIS, K. M., HARRINGTON, R. A., DECKERS, J. W. and ARMSTRONG, P. W., 2000. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation: Results From an International Trial of 9461 Patients Circulation (Baltimore). VOL 101(PART 22), 2557-2567
AKKERHUIS, K M, NEUHAUS, K L, WILCOX, R G, VAHANIAN, A, BOLAND, J L, HOFFMANN, J, BAARDMAN, T, NEHMIZ, G, ROTH, U, KLOOTWIJK, A P, DECKERS, J W, SIMOONS, M L and ,, 2000. European Heart Journal. 21(24), 2042-55
KLEIMAN, N S, LINCOFF, A M, FLAKER, G C, PIEPER, K S, WILCOX, R G, BERDAN, L G, LORENZ, T J, COKKINOS, D V, SIMOONS, M L, BOERSMA, E, TOPOL, E J, CALIFF, R M and HARRINGTON, R A, 2000. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation (New York, N.Y.). 101(7), 751-7
HASDAI, D, HOLMES, D R, CRIGER, D A, TOPOL, E J, CALIFF, R M, WILCOX, R G, PAOLASSO, E, SIMOONS, M, DECKERS, J and HARRINGTON, R A, 2000. American Heart Journal. 139(3), 454-60
WILCOX, R.G., BRAUNWALD, E., ANTMAN, E. and SKENE, A., 2000. European Heart Journal. 21, 2005-2013
TOPOL, E. J., OHMAN, E. M., ARMSTRONG, P. W., WILCOX, R., SKENE, A. M., AYLWARD, P., SIMES, J., DALBY, A., BETRIU, A. and BODE, C., 2000. Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial Circulation (Baltimore). VOL 102(PART 15), 1761-1765
WONG, C.K., WHITE, H.D., WILCOX, R.G., CRIGER, D.A., CALIFF, R.M., TOPOL, E.J. and OHMAN, E.M., 2000. Does antiarrhythmic treatment alter outcome in AF complicating acute MI? The GUSTO III experience. Circulation (Baltimore). 102(18), 2779 Suppl.S
WILCOX, R, 2000. European Heart Journal. 21(18), 1495-7
BERTRAND, M.E., RUPPRECHT, H.J., GERSHLICK, A.H. and WILCOX, R.G., 2000. Double-blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination with Aspirin Compared with Ticlopidine in Combination with Aspirin After Coronary Stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) Circulation (Baltimore). 102, 624-629
CANNON, C P, MCCABE, C H, WILCOX, R G, LANGER, A, CASPI, A, BERINK, P, LOPEZ-SENDON, J, TOMAN, J, CHARLESWORTH, A, ANDERS, R J, ALEXANDER, J C, SKENE, A and BRAUNWALD, E, 2000. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation (New York, N.Y.). 102(2), 149-56
AKKERHUIS, K M, DECKERS, J W, BOERSMA, E, HARRINGTON, R A, STEPINSKA, J, MAHAFFEY, K W, WILCOX, R G, LINCOFF, A M, KELTAI, M, TOPOL, E J, CALIFF, R M and SIMOONS, M L, 2000. European Heart Journal. 21(5), 371-81
BROWN, N, MELVILLE, M, GRAY, D, YOUNG, T, SKENE, A M, WILCOX, R G and HAMPTON, J R, 1999. Heart. 81(6), 598-602
AL-RUWAITEA, A S, CHIANG, T J, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Psychopharmacology. 144(3), 264-71
PHILLIPS, M A, SZABADI, E and BRADSHAW, C M, 1999. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone. Journal of Psychopharmacology. 13(4), 391-7
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1999. Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. Journal of Psychopharmacology. 13(1), 3-9
HO, M.-Y., MOBINI, S., CHIANG, T.-J., BRADSHAW, C. M. and SZABADI, E., 1999. Psychopharmacology. VOL 146(NUMBER 4), 362-372
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1999. Psychopharmacology. VOL 143(NUMBER 3), 286-292
ABDEBNAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1999. British Journal of Clinical Pharmacology. VOL 48(NUMBER 3), 345-354
CHIANG, T J, AL-RUWAITEA, A S, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Psychopharmacology. 143(2), 166-73
AL-RUWAITEA, A. S. A., CHIANG, T.-J., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1999. Psychopharmacology. VOL 141(NUMBER 1), 22-29
DAVIS, C, BRADSHAW, C M and SZABADI, E, 1999. British Journal of Clinical Psychology. 38 ( Pt 3), 305-14
VIDALAKI, V.N., HO, M.-Y., BRADSHAW, C.M. and SZABADI, E., 1999. Neuropsychologia. VOL 37(NUMBER 9), 1061-1070
BITSIOS, P., PHILPOTT, A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 1999. Journal of Psychopharmacology. VOL 13(NUMBER 3), 226-234
WILCOX, R., 1999. Heart. VOL 82(NUMBER 4), 405
WILCOX, R.G., 1999. Trial of early nifedipine in acute myocardial infarction: the TRENT Study. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 323-334
HASDAI, D., HOLMES, D. R., TOPOL, E. J., BERGER, P. B., CRIGER, D. A., HOCHMAN, J. S., BATES, E. R., VAHANIAN, A., ARMSTRONG, P. W. and WILCOX, R., 1999. European Heart Journal. VOL 20(NUMBER 2), 128-135
WILCOX, R.G., 1999. Anglo Scandinavian Study of Early Thrombolysis: ASSET. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 15-24
ALEXANDER, J. H., HARRINGTON, R. A., TUTTLE, R. H., BERDAN, L. G., LINCOFF, A. M., DECKERS, J. W., SIMOONS, M. L., GUERCI, A., HOCHMAN, J. S. and WILCOX, R. G., 1999. American Journal of Cardiology. VOL 83(NUMBER 8), 1147-1151
WILCOX, R.G., ANTMAN, E., BRAUNWALD, E., NEUHAUS, K. and SKENE, A.M., 1999. In-Time II: an equivalence trial of single bolus lanoteplase vs. accelerated alteplase in patients with acute myocardial infarction Heart. 81 Suppl.1, 38
OHMAN, E M, ARMSTRONG, P W, WHITE, H D, GRANGER, C B, WILCOX, R G, WEAVER, W D, GIBLER, W B, STEBBINS, A L, CIANCIOLO, C, CALIFF, R M and TOPOL, E J, 1999. American Journal of Cardiology. 84(11), 1281-6
STOREY, R.F., OLDROYD, K.G. and WILCOX, R.G., 1999. First clinical study of the novel platelet ADP receptor (P2T-) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes Circulation (Baltimore). 100, I-710
STOREY, R F, WILCOX, R G and HEPTINSTALL, S, 1998. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation (Baltimore). 98(16), 1616-21
SZABADI, E., BRADSHAW, C. M., BOSTON, P. F. and LANGLEY, R. W., 1998. Human Psychopharmacology: Clinical and Experimental. VOL 13 SUPP/1, S3-S12
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1998. British Journal of Clinical Pharmacology. VOL 45(NUMBER 3), 271-276
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1998. Journal of Psychopharmacology. 12(3), 239-45
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. Psychopharmacology. VOL 135(NUMBER 1), 93-98
BITSIOS, P., LANGLEY, R. W., TAVERNOR, S., PYYKKOE, K., SCHEININ, M., SZABADI, E. and BRADSHAW, C. M., 1998. British Journal of Clinical Pharmacology. VOL 45(NUMBER 6), 551-558
WOGAR, M. A., VAN DEN BROEK, M. D., BRADSHAW, C. M. and SZABADI, E., 1998. A new performance-curve method for the detection of simulated cognitive impairment British Journal of Clinical Psychology. VOL 37(NUMBER 3), 327-340
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. Journal of Psychopharmacology. VOL 12(NUMBER 2), 137-145
HO, M.-Y., AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1998. Journal of Psychopharmacology. VOL 12(NUMBER 1), 68-78
CHIANG, T.-J., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. Behavioural Processes. VOL 44(ISSUE 2), 197-209
AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. Psychopharmacology. VOL 136(NUMBER 3), 235-242
BRIERLEY, C E, SZABADI, E, RIX, K J and BRADSHAW, C M, 1998. Journal of Affective Disorders. 15(1), 45-54
WILCOX, R.G., 1998. New England Journal of Medicine. 339, 436-43
WILCOX, R.G., 1998. Horizons in Medicine
GIBLER, W. B., WILCOX, R. G., BODE, C., CASTAIGNE, A. D., DELOOZ, H., ELICH, D., FOX, K. A. A., KEREIAKES, D. J., RUPPRECHT, H. and TOPOL, E. J., 1998. Annals of Emergency Medicine. VOL 32(NUMBER 6), 712-722
ARYA, D. K., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 355(NUMBER 3), 376-383
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. British Journal of Clinical Pharmacology. VOL 44(NUMBER 1), 61-68
HO, M.-Y., WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1997. Choice between Delayed Reinforcers: Interaction between Delay and Deprivation Level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. VOL 50(NUMBER 3), 193-202
AL-RUWAITEA, A. S. A., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 134(NUMBER 2), 179-186
AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 130(NUMBER 2), 166-173
AL-ZAHRANI, S. S. A., HO, M.-Y., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1997. Psychopharmacology. VOL 129(NUMBER 1), 48-55
AL-RUWAITEA,A.S., AL-ZAHRANI,S.S., HO,M., BRADSHAW,C.M. and SZABADI,E., 1997. 5-Hydroxytryptamine and interval timing.. In: BRADSHAW, C.M., ed., Time and behaviour: psychological and neurobehavioural analyses . Elsevier. 517-570
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1997. Journal of Psychopharmacology. 11(1), 29-34
BRADSHAW, C.M. and SZABADI, E., eds., 1997. Time and behaviour: psychological and neurobehavioural analyses Elsevier.
WILCOX, R.G., 1997. New England Journal of Medicine. 337, 1124-30
WILCOX, R.G., 1997. New England Journal of Medicine. 337, 1118-23
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. Journal of Pharmacological and Toxicological Methods. VOL 36(NUMBER 2), 77-80
BITSIOS, P, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 1996. British Journal of Clinical Pharmacology. 41(4), 269-75
MORTLOCK, S A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1996. British Journal of Clinical Pharmacology. 42(2), 236-8
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 354(NUMBER 1), 25-29
ABDELMAWLA, A. H., LANGLEY, R. W., SZAHADI, E. and BRADSHAW, C. M., 1996. Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 353(NUMBER 3), 324-327
AL-ZAHRANI, S S, HO, M Y, VELAZQUEZ MARTINEZ, D N, LOPEZ CABRERA, M, BRADSHAW, C M and SZABADI, E, 1996. Psychopharmacology. 127(4), 346-52
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1996. Journal of Psychopharmacology. VOL 10(NUMBER 4), 279-287
AL-ZAHRANI, S S, HO, M Y, MARTINEZ, D N, CABRERA, M L, BRADSHAW, C M and SZABADI, E, 1996. Psychopharmacology. 123(1), 103-10
SZABADI, E. and BRADSHAW, C. M., 1996. Autonomic pharmacology of 脿~2-adrenoceptors Journal of Psychopharmacology. VOL 10(NUMBER SUP//3), 6-18
HO, M.-Y., AL-ZAHRANI, S. S. A., VELAZQUEZ MARTINEZ, D. N., LOPEZ CABRERA, M., BRADSHAW, C. M. and SZABADI, E., 1996. Psychopharmacology. VOL 125(NUMBER 3), 274-284
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1995. Comparison of the effects of desipramine on noradrenaline-and methoxamine-evoked venoconstriction in man British Journal of Clinical Pharmacology. VOL 40(NUMBER 5), 445
SZABADI,E. and BRADSHAW,C.M., 1995. Affective disorders: Antidepressants. In: KING, D.J, ed., Seminars in Clinical Psychopharmacology 138-192
HO,M.Y., AL-ZAHRANI,S.S., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., BRADSHAW,C.M. and SZABADI,E., 1995. Psychopharmacology. 120(2), 213-219
THEOFILOPOULOS, N, MCDADE, G, SZABADI, E and BRADSHAW, C M, 1995. British Journal of Clinical Pharmacology. 39(3), 251-5
HO,M.Y., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., AL-ZAHRANI,S.S., BRADSHAW,C.M. and SZABADI,E., 1995. Psychopharmacology. 118(3), 332-337
GRAHAM, S, HO, M Y, BRADSHAW, C M and SZABADI, E, 1994. Psychopharmacology. 116(3), 373-8
MORRISSEY, G., HO, M.-Y., WOGAR, M. A. and BRADSHAW, C. M., 1994. Psychopharmacology. VOL 114(NUMBER 3), 463
VAN DEN BROEK, M D and BRADSHAW, C M, 1994. Detection of acquired deficits in general intelligence using the National Adult Reading Test and Raven's Standard Progressive Matrices. British Journal of Clinical Psychology. 33 ( Pt 4), 509-15
BOURNE, M., SZABADI, E. and BRADSHAW, C. M., 1993. European Journal of Clinical Pharmacology. VOL 44(NUMBER 1), 57
WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1993. Psychopharmacology. VOL 111(NUMBER 2), 239
BRADSHAW, C. M. and SZABADI, E., 1993. Herrnstein's Equation: Data From 110 Rats Psychological Reports. VOL 73(NUMBER 3//PT2), 1355
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1993. Utility of the Wisconsin Card Sorting Test in neuropsychological assessment British Journal of Clinical Psychology. 32(3), 333-343
MORRISSEY, G., WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1993. Psychopharmacology. VOL 112(NUMBER 1), 80
WOGAR, M A, BRADSHAW, C M and SZABADI, E, 1993. Psychopharmacology. 112(1), 86-92
VANDENBROEK,M.D. and BRADSHAW,C.M., 1993. Personality and Individual Differences. 14(4), 531-534
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. The relationship between Personality and Individual Differences. 13(3), 355-360
WOGAR,M.A., BRADSHAW,C.M. and SZABADI,E., 1992. Choice between delayed reinforcers in an adjusting-delay schedule: the effects of absolute reinforcer size and deprivation level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 45B(1), 1-13
LEUNG, N K, BRADSHAW, C M and SZABADI, E, 1992. Effect of high ambient temperature on the kinetics of the pupillary light reflex in healthy volunteers. British Journal of Clinical Pharmacology. 33(4), 458-60
FLETT,S.R., SZABADI,E. and BRADSHAW,C.M., 1992. European Journal of Clinical Pharmacology. 42, 529-533
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. Personality and Individual Differences. 13(2), 169-174
BRADSHAW, C M and SZABADI, E, 1992. Choice between delayed reinforcers in a discrete-trials schedule: the effect of deprivation level. Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 44(1), 1-6
WOGAR, M A, BRADSHAW, C M and SZABADI, E, 1992. Psychopharmacology. 107(2-3), 373-8
WOGAR,M.A., BRADSHAW,C.M. and SZABADI,E., 1991. Psychopharmacology. 105(1), 119-124
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1991. Relative and absolute reinforcement frequency as determinants of choice in concurrent variable interval schedules Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 43B(1), 25-38
SZABADI, E. and BRADSHAW, C.M., eds., 1991. Adrenoceptors: Structure, Mechanisms, Function Birkhauser.
LONGMORE,J., BERRY,J.L., SZABADI,E. and BRADSHAW,C.M., 1990. European Journal of Clinical Pharmacology. 39, 305-309
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1990. Psychopharmacology. 100(4), 548-554
BAKES,A., BRADSHAW,C.M. and SZABADI,E., 1990. Attenuation of the pupillary light reflex in anxious patients British Journal of Clinical Pharmacology. 30, 377-381
VANDENBROEK,M.D. and BRADSHAW,C.M., 1990. Intellectual decline and the assessment of premorbid intelligence. In: BEECH,J. R. and HARDING L, eds., Assessment of the Elderly NFER-Nelson, London.
THEOFILOPOULOS, N., GRAY, C.M., SZABADI, E. and BRADSHAW, C.M., 1989. Human Psychopharmacology: Clinical and Experimental. 4, 129-134
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1989. Performance of humans in concurrent variable ratio schedules of monetary reinforcement. Psychological Reports. 65(2), 515-520
BRADSHAW,C.M. and SZABADI,E., 1989. Central neurotransmitter systems and the control of operant behaviour by. In: LIEBMAN, J.M. and COOPER, S.J, eds., The Neuropharmacological Basis of Reward, Clarendon Press.
BANJAR, W M, BRADSHAW, C M and SZABADI, E, 1989. Seasonal variation in responsiveness of human eccrine sweat glands to phenylephrine. British Journal of Clinical Pharmacology. 27(2), 276-8
SZABADI,E. and BRADSHAW,C.M., 1988. Biological markers for anxiety states. In: GRANVILLE-GROSSMAN,K.L. and WING,P., eds., Recent Advances in Clinical Psychiatry 6. Churchill Livingstone. 69-99
LONGMORE, J, BANJAR, W, BRADSHAW, C M and SZABADI, E, 1988. European Journal of Clinical Pharmacology. 34(1), 97-9
THEOFILOPOULOS, N, LONGMORE, J, KERR, F A, SZABADI, E and BRADSHAW, C M, 1988. British Journal of Clinical Pharmacology. 26(6), 697-702
MORLEY, M J, SHAH, K, BRADSHAW, C M and SZABADI, E, 1988. Psychopharmacology. 96(4), 551-6
BRADSHAW,C.M. and SZABADI,E., 1988. Quantitative analysis of human operant behavior. In: DAVEY,G. and CULLEN,C., eds., Human Operant Conditioning and Behavior Modification John Wiley & Sons. 225-259
BRADSHAW, C.M., 1988. Biological markers for anxiety states. In: Recent Advances in Clinical Psychiatry 6. 69-99
VAN DEN BROEK, M D, BRADSHAW, C M and SZABADI, E, 1987. Performance of normal adults on the Matching Familiar Figures Test. British Journal of Clinical Psychology. 26 ( Pt 1), 71-2
SZABADI,E. and BRADSHAW,C.M., 1987. Alpha 1 adrenergic receptors in the central nervous system. In: RUFFOLO,R.R., ed., The Alpha 1 Adrenergic Receptors Humana Press. 405-453
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1987. Behaviour of Personality and Individual Differences. 8(2), 233-239
MORLEY,M.J., BRADSHAW,C.M. and SZABADI,E., 1987. Psychopharmacology. 92(2), 247-253
MORLEY, M J, BRADSHAW, C M and SZABADI, E, 1987. Psychopharmacology. 93(4), 520-5
MORLEY,M.J., BRADSHAW,C.M. and SZABADI,E., 1987. Psychopharmacology. 91(2), 239-243
LONGMORE, J, BANJAR, W, SZABADI, E and BRADSHAW, C M, 1987. British Journal of Clinical Pharmacology. 23(2), 245-6
BANJAR, W, LONGMORE, J, BRADSHAW, C M and SZABADI, E, 1987. European Journal of Clinical Pharmacology. 31(6), 661-5
BRADSHAW, C.M., SHERIDAN, R.D. and SZABADI, E., 1987. Neuropharmacology. 26, 1195-1200
SZABADI,E. and BRADSHAW,C.M., 1986. Antidepressant drugs and the autonomic nervous system. In: DEAKIN,J.F.W., ed., The Biology of Depression Gaskell. 190-220
LONGMORE, J, JANI, B, BRADSHAW, C M and SZABADI, E, 1986. British Journal of Clinical Pharmacology. 21(2), 131-5